HUT59419A - Process for producing amino acid derivatives - Google Patents

Process for producing amino acid derivatives

Info

Publication number
HUT59419A
HUT59419A HU912979A HU297991A HUT59419A HU T59419 A HUT59419 A HU T59419A HU 912979 A HU912979 A HU 912979A HU 297991 A HU297991 A HU 297991A HU T59419 A HUT59419 A HU T59419A
Authority
HU
Hungary
Prior art keywords
amino acid
acid derivatives
producing amino
producing
derivatives
Prior art date
Application number
HU912979A
Other languages
English (en)
Other versions
HU912979D0 (en
Inventor
Keiji Hemmi
Hiroshi Marusawa
Masashi Hashimoto
Masahiro Neya
Shinya Watanabe
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909020305A external-priority patent/GB9020305D0/en
Priority claimed from GB919105580A external-priority patent/GB9105580D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HU912979D0 publication Critical patent/HU912979D0/hu
Publication of HUT59419A publication Critical patent/HUT59419A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU912979A 1990-09-17 1991-09-16 Process for producing amino acid derivatives HUT59419A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909020305A GB9020305D0 (en) 1990-09-17 1990-09-17 New amino acid derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
GB919105580A GB9105580D0 (en) 1991-03-15 1991-03-15 New amino acid derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
HU912979D0 HU912979D0 (en) 1992-01-28
HUT59419A true HUT59419A (en) 1992-05-28

Family

ID=26297665

Family Applications (1)

Application Number Title Priority Date Filing Date
HU912979A HUT59419A (en) 1990-09-17 1991-09-16 Process for producing amino acid derivatives

Country Status (15)

Country Link
US (1) US5491132A (hu)
EP (1) EP0476515A1 (hu)
JP (2) JP2641823B2 (hu)
KR (1) KR920006326A (hu)
CN (1) CN1030922C (hu)
AU (1) AU646076B2 (hu)
CA (1) CA2051455A1 (hu)
FI (1) FI914309A (hu)
HU (1) HUT59419A (hu)
IE (1) IE913220A1 (hu)
IL (1) IL99389A0 (hu)
NO (1) NO913644L (hu)
PT (1) PT98984A (hu)
RU (1) RU2057124C1 (hu)
TW (1) TW212176B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430022A (en) * 1990-05-14 1995-07-04 Fujisawa Pharmaceutical Co., Ltd. Peptide compound and its preparation
GB9127041D0 (en) * 1991-12-20 1992-02-19 Fujisawa Pharmaceutical Co New use
AU6581194A (en) * 1993-04-28 1994-11-21 Fujisawa Pharmaceutical Co., Ltd. Oral pharmaceutical compositions containing renin inhibitors
GB9313330D0 (en) * 1993-06-28 1993-08-11 Fujisawa Pharmaceutical Co New compound and its preparation
GB2281709B (en) * 1993-09-14 1998-04-08 Fujitsu Ltd Biodegradable resin moulded article
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668769A (en) * 1985-08-02 1987-05-26 Hoover Dennis J Oxa- and azahomocyclostatine polypeptides
ZA87563B (en) * 1986-02-03 1987-09-30 Squibb & Sons Inc N-heterocyclic alcohol renin inhibitors
GB8707412D0 (en) * 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
US5223489A (en) * 1987-06-22 1993-06-29 Ujisawa Pharmaceutical Co., Ltd. Amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US4921855A (en) * 1987-06-22 1990-05-01 Fujisawa Pharmaceutical Co., Ltd. New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives
US5256645A (en) * 1988-03-04 1993-10-26 Hoffmann-La Roche Inc. Amino acid derivatives
US4981843A (en) * 1988-04-07 1991-01-01 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol derivatives
EP0391180A3 (de) * 1989-04-04 1991-04-03 F. Hoffmann-La Roche Ag Peptidartige Aminosäurederivate mit reninhemmender Wirkung

Also Published As

Publication number Publication date
PT98984A (pt) 1992-07-31
CN1063691A (zh) 1992-08-19
JP2641823B2 (ja) 1997-08-20
HU912979D0 (en) 1992-01-28
NO913644L (no) 1992-03-18
NO913644D0 (no) 1991-09-16
CN1030922C (zh) 1996-02-07
CA2051455A1 (en) 1992-03-18
AU646076B2 (en) 1994-02-03
AU8379091A (en) 1992-03-19
FI914309A0 (fi) 1991-09-13
TW212176B (hu) 1993-09-01
JPH04279570A (ja) 1992-10-05
FI914309A (fi) 1992-03-18
US5491132A (en) 1996-02-13
RU2057124C1 (ru) 1996-03-27
JPH08283244A (ja) 1996-10-29
EP0476515A1 (en) 1992-03-25
IL99389A0 (en) 1992-08-18
IE913220A1 (en) 1992-02-25
KR920006326A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
HU910400D0 (en) Process for producing 3-aryl-carbonyl-1h-indole derivatives
HU9200253D0 (en) Process for the production of amino acid derivatves
HU911492D0 (en) Process for producing bis-aryl-amide and -urea derivatives
HU912166D0 (en) Process for the production of dipeptide derivatives
HU905676D0 (en) Process for producing aminoacid derivatives
HUT59939A (en) Process for producing glycolic acid derivatives
EP0551596A3 (en) Process for producing naphtalenedicarboxylic acid
HUT53876A (en) Improved process for producing guanidine derivatives
HU912097D0 (en) Process for the production of amino acid derivatives
HUT53663A (en) Process for producing amino acid derivatives
HU912639D0 (en) Process for producing (fluor-ethyl)-camptotecine derivatives
HUT59388A (en) Process for producing 8-chloroquinolone derivatives
HU912693D0 (en) Process for producing indolo-naphtyridine derivatives
HUT59419A (en) Process for producing amino acid derivatives
HU912732D0 (en) Process for producing 1-alkyl-isoquinoline derivatives
KR0156581B1 (en) 1,4-benzothiazine-2-acetic acid derivatives and process for production
HU910326D0 (en) Process for producing 2-chloro-5-methyl-pyridine derivatives
EP0469517A3 (en) Process for producing l-glutamic acid
HU910466D0 (en) Process for producing 7-amino-3-methoxy-methyl-cef-3-em-4-carboxylic acid
HUT49324A (en) Process for producing 2-oximino-3-oxo-butiric acid derivatives
HUT58284A (en) Process for producing alkyl-sulfonanilide derivatives
HU912413D0 (en) Process for producing n-alkyl-sulfonyl-amino-sulfonyl-urea derivatives
IL104013A0 (en) Process for preparing 4-amino-5-hexenoic acid
HU9203580D0 (en) Method for producing amino acid derivatives
HUT57734A (en) Process for producing pyrazaolecarboxylic acid derivatives

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal